deltatrials
Unknown PHASE3 INTERVENTIONAL 1-arm NCT02537067

Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle for 18 Months

Sponsor: Sewon Cellontech Co., Ltd.

Conditions Ankle (Ligaments); Instability, Familial Defect of Articular Cartilage Degenerative Joint Disease of Ankle and/or Foot
Interventions CHONDRON
Updated 7 times since 2017 Last updated: Aug 28, 2015 Started: Jan 31, 2010 Primary completion: May 31, 2015 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Ankle (Ligaments); Instability, Familial and Defect of Articular Cartilage and is currently ongoing. Sewon Cellontech Co., Ltd. leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotActive Not Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

▶ Show 2 earlier versions

  1. Sep 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

  2. Jan 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sewon Cellontech Co., Ltd.
Data source: Sewon Cellontech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations